Vaccine failures after primary immunisation with Haemophilus influenzae type-b conjugate vaccine without booster

Lancet

Volumn 349, Issue 9060, 1997, Pages 1197-1202

  Booy, Robert ^a   Heath, Paul T ^b   Slack, P E Mary ^c   Begg, Norman ^d   Richard Moxon, E ^b  

^a ST MARY S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c PHLS Haemophilus Reference Unit   (United Kingdom)

^d PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE; PRP TETANUS CONJUGATE VACCINE; TETANUS TOXOID; UNCLASSIFIED DRUG;

ARTICLE; DRUG EFFICACY; GRAM NEGATIVE INFECTION; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; INFANT; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; TREATMENT FAILURE; UNITED KINGDOM; VACCINATION;

EID: 0030994011     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)06392-1     Document Type: Article

References (27)

1. Moxon ER, Vaughn KA The type b capsular polysaccharide as a virulence determinant of Haemophilus influenzae: studies using clinical isolates and laboratory transformants. J Infect Dis. 143:1981;517-524.
2. Eskola J, Peltola H, Takala AKet al. Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy. N Engl J Med. 317:1987;717-722.
3. Santosham M, Wolff M, Reid Ret al. The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer membrane protein complex. N Engl J Med. 324:1991;1767-1772.
4. Black SB, Shinefield HR, Fireman Bet al. Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61 080 children. Pediatr Infect Dis J. 10:1991;97-104.
5. Booy R, Hodgson S, Carpenter Let al. Efficacy of Haemophilus influenzae type b conjugate vaccine PRP-T. Lancet. 344:1994;362-366.
6. Adams WG, Deaver KA, Cochi SL Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine Era. JAMA. 269:1993;221-226.
7. Peltola H, Kilpi T, Anttila M Rapid disappearance of Haemophilus influenzae type b meningitis after routine childhood immunisation with conjugate vaccines. Lancet. 340:1992;592-594.
8. Clements DA, Booy R, Dagan Ret al. Comparison of the epidemiology and cost of Haemophilus influenzae type b disease in five western countries. Pediatr Infect Dis J. 12:1993;362-367.
9. Falla TJ, Crook DWM, Brophy LN, Maskell D, Kroll JS, Moxon ER Polymerase chain reaction for capsular typing of Haemophilus influenzae. J Clin Microbiol. 32:1994;2382-2386.
10. Gardner MJ, Altman DG. Statistics with confidence. London: BMJ, 1989.
11. Booy R, Hodgson SA, Slack MPE, Anderson EC, Mayon-White RT, Moxon ER Invasive Haemophilus influenzae type b disease in the Oxford region (1985-91). Arch Dis Child. 69:1993;225-228.
12. White JM, Leon S, Begg NT "COVER" (Cover of vaccination evaluated rapidly); 29. Commun Dis Rep CDR Rev. 4:1994;51-52.
13. O'Brien H Hib immunisation catch up program in North East Thames. Commun Dis Rep CDR Rev. 4:1994;17-18.
14. Takala AK, Eskola J, Leionen Met al. Reduction of oropharyngeal carriage of the Haemophilus influenzae type b (Hib) in children immunised with an Hib conjugate vaccine. J Infect Dis. 164:1991;982-986.
15. Barbour ML, Mayon-White RT, Coles C, Crook DWM, Moxon ER The impact of conjugate vaccine on carriage on Haemophilus influenzae type b. J Infect Dis. 171:1995;93-98.
16. White JM, Leon S, Begg NT 'COVER' (Cover of vaccination evaluated rapidly): 26. Commun Dis Rep CDR Rev. 3:1993;117-118.
17. Howard AJ, Dunkin KT, Musser JM, Palmer SR Epidemiology of Haemophilus influenzae type b invasive disease in Wales. BMJ. 303:1991;441-445.
18. Nazareth B, Slack MB, Howard AJ, Waight PA, Begg NT A survey of invasive Haemophilus influenzae infections. Commun Dis Rep CDR Rev. 2:1992;13-16.
19. Urwin G, Yuan MF, Feldman RA Prospective study of bacterial meningitis in North East Thames Region, 1991-3, during introduction of Haemophilus influenzae vaccine. BMJ. 309:1994;1412-1414.
20. Booy R, Taylor SA, Dobson SRMet al. Immunogenicity and safety of PRP-T conjugate vaccine given according to the British accelerated immunisation schedule. Arch Dis Child. 67:1992;475-478.
21. Marketing Pocket Book 1990. The Advertising Association. 1990: 10.
22. Teare EL, Fairley CK, White J, Begg N Efficacy of Hib vaccine. Lancet. 144:1994;828-829.
23. Cates KL, Krause PJ, Murphy TV, Stutman HR, Granoff DM Second episodes of Haemophilus influenzae type b disease following rifampicin prophylaxis of the index patients. Pediatr Infect Dis J. 6:1987;512-515.
24. Kahyty H, Eskola J, Peltola MDet al. Antibody responses to four Haemophilus influenzae type b conjugate vaccine. Am J Dis Child. 145:1991;123-227.
25. Castillo De Febues O, Decket MD, Estopinan M, Boudones G, Edwards KM Enhanced antibody response in Venezuelan infants immunized with Haemophilus influenzae type b-tetanus toxoid conjugate vaccine. Pediatr Infect Dis J. 13:1994;635-639.
26. Black SB, Shinefield HR Northern California Kaiser Permanente medical care program department of Paediatrics vaccine study group. b-CAPSA I Haemophilus influenzae, type b, capsular polysaccaride vaccine safety. Paediatrics. 79:1987;321-325.
27. Delaporte R Assessing the human condition: capture-recapture techniques. BMJ. 308:1994;5-6.